GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Cirrhosis Liver/Liver POCUS - A New Bedside Skill for Modern Hepatology: Hepatology Communications | September 2026
4

Liver POCUS - A New Bedside Skill for Modern Hepatology: Hepatology Communications | September 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2026

Introduction:

Point-of-care ultrasound (POCUS) allows hepatologists to perform and interpret focused ultrasonography at the bedside or during the clinic visit, integrating imaging findings immediately into clinical decision-making. Unlike conventional radiology-based ultrasonography, liver POCUS is designed to answer specific clinical questions in real time and should be viewed as an extension of the physical examination rather than a replacement for formal ultrasound.

This AASLD position paper provides a practical roadmap for incorporating liver POCUS into hepatology practice, including clinical indications, examination protocols, training, credentialing, documentation, image storage, billing, and implementation.

20 Key Takeaways:

Liver POCUS complements conventional ultrasound; it does not replace it. Its main advantage is immediate bedside integration with the clinical assessment.

Liver POCUS can rapidly evaluate ascites, liver morphology, steatosis, splenomegaly, portal vein patency, biliary dilatation, and intravascular volume status.

In chronic liver disease, POCUS can identify surface nodularity, altered liver contour, and other morphological clues to cirrhosis.

Ascites detection is one of the simplest and most useful applications, particularly for confirming fluid, monitoring response to diuretics, and planning paracentesis.

POCUS can assess spleen size, providing additional information about portal hypertension when interpreted alongside platelet count and other clinical findings.

Doppler assessment can identify normal versus abnormal portal venous flow and raise suspicion for portal vein thrombosis requiring formal imaging.

Liver–kidney echogenicity comparison provides a practical bedside method for recognizing hepatic steatosis.

POCUS may assist in evaluating elevated liver enzymes by identifying steatosis, gallstones, biliary dilatation, cirrhotic morphology, or vascular abnormalities.

In hospitalized patients, POCUS can be repeated serially to assess ascites, portal vasculature, biliary obstruction, and changing volume status.

Assessment of the inferior vena cava (IVC) may help guide fluid or albumin administration, particularly in cirrhosis with acute kidney injury, although interpretation must remain clinically integrated.

POCUS improves the safety of bedside procedures such as paracentesis and liver biopsy by defining anatomy and guiding needle placement.

Advanced applications may eventually include shear-wave elastography, post-transplant vascular assessment, targeted liver biopsy, and other ultrasound-guided procedures.

A standard liver POCUS examination should include three core views: mid-abdominal/subxiphoid, right intercostal, and left intercostal.

The mid-abdominal view evaluates liver parenchyma, hepatic and portal veins, IVC, and gallbladder.

The right intercostal view is particularly useful for assessing the right hepatic lobe, liver–kidney contrast, ascites, and portal venous flow.

The left intercostal view is primarily used to assess the spleen and identify splenomegaly.

AASLD proposes a minimum training pathway of at least 2 hours of liver ultrasound didactic education followed by ≥25 supervised liver POCUS examinations.

Completion of minimum case numbers establishes basic competency, but true proficiency requires continued practice and ongoing quality assessment.

Clinical implementation requires more than purchasing an ultrasound device: programs need credentialing, IT integration, image archiving, standardized reporting, documentation, and collaboration with radiology and institutional POCUS teams.

The long-term vision is for liver POCUS to become a routine hepatology competency, potentially expanding into elastography, vascular assessment, procedural guidance, and other ultrasound-based diagnostic and therapeutic applications.

Clinical Impact:

Liver POCUS has the potential to change the hepatology visit from a predominantly history-and-examination encounter into a real-time clinical–imaging assessment. Its greatest immediate value lies in focused questions—particularly ascites, portal hypertension, volume status, steatosis, and procedural guidance—where rapid answers can directly change management.

Bottom Line:

AASLD supports liver POCUS as an emerging core skill for hepatologists. With structured training, supervised competency assessment, appropriate credentialing, and strong clinical governance, bedside ultrasound can become an extension of the hepatology examination and significantly enhance real-time decision-making.

Related Q&A

05

Increased Thrombin Generation Predicts First Decompensation in Compensated Cirrhosis: Hepatology Communications | August 2026

Introduction: Cirrhosis is no longer considered simply a bleeding disorder but a state of rebalanced and sometimes prothrombotic haemostasis. Whether this hypercoagulable phenotype contributes directly to disease progression...

06

Machine Learning Identifies Three Distinct Ascites Phenotypes in Cirrhosis: Liver Transplantation | August 2026

Introduction: Ascites marks a major transition in cirrhosis, yet patients with apparently similar ascites can have markedly different clinical trajectories. This multicenter study used machine learning-based latent class...

07

Cardiac Assessment Before TIPSS: Frontline Gastroenterology | August 2026

Introduction: Transjugular intrahepatic portosystemic shunt (TIPSS) is highly effective for portal hypertensive complications, but the sudden increase in venous return can precipitate cardiac decompensation, particularly in patients with...

08

Contemporary Global Epidemiology of Cirrhosis: Hepatology Communications | August 2026

Key Takeaways: 1. Cirrhosis remains a major global health challenge, causing approximately 1.4 million deaths worldwide in 2021, despite improvements in prevention and treatment. 2. The absolute burden...

09

Contemporary Global Epidemiology of Cirrhosis: Hepatology Communications | August 2026

Key Takeaways: 1. Cirrhosis remains a major global health challenge, causing approximately 1.4 million deaths worldwide in 2021, despite improvements in prevention and treatment. 2. The absolute burden...

10

POCUS-Guided AKI Management in Cirrhosis: Hepatology | July 2026

Introduction: Acute kidney injury (AKI) is a frequent and life-threatening complication of cirrhosis, with management often complicated by inaccurate assessment of intravascular volume and the presence of cirrhotic...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer